Cartesian Therapeutics In...

NASDAQ: RNAC · Real-Time Price · USD
11.33
-0.10 (-0.87%)
At close: Aug 15, 2025, 3:59 PM
11.80
4.15%
After-hours: Aug 15, 2025, 06:53 PM EDT

Cartesian Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
38.91M 26M 110.78M 85.08M
Cost of Revenue
n/a 1.55M 2.04M n/a
Gross Profit
38.91M 24.45M 108.74M 85.08M
Operating Income
-43.9M -86.42M 14.54M -4.6M
Interest Income
7.39M n/a n/a n/a
Pretax Income
-77.14M -238.71M 34.77M -9.72M
Net Income
-77.42M -219.71M 35.38M -25.69M
Selling & General & Admin
30.13M 40.58M 23.86M 20.94M
Research & Development
45.1M 71.84M 72.38M 68.74M
Other Expenses
7.58M n/a 330K 15K
Operating Expenses
82.81M 110.87M 96.24M 89.67M
Interest Expense
n/a 2.83M 3.03M 2.84M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
82.81M 112.42M 96.24M 89.67M
Income Tax Expense
287K -19M -609K 15.97M
Shares Outstanding (Basic)
25.91M 5.17M 4.02M 3.18M
Shares Outstanding (Diluted)
155.11M 5.17M 4.05M 3.18M
EPS (Basic)
-2.99 -49.76 7.20 -6.74
EPS (Diluted)
-0.5 -49.76 3.00 -6.74
EBITDA
-77.14M -235.06M 39.84M -5.16M
EBIT
-77.14M -235.88M 37.8M -6.88M
Depreciation & Amortization
n/a 843K 2.04M 1.72M